HBM Holdings Limited

SEHK:2142 Stock Report

Market Cap: HK$879.3m

HBM Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jingsong Wang

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage55.8%
CEO tenure8.3yrs
CEO ownership8.4%
Management average tenureless than a year
Board average tenure4.3yrs

Recent management updates

Recent updates

Investors Still Aren't Entirely Convinced By HBM Holdings Limited's (HKG:2142) Revenues Despite 30% Price Jump

Oct 02
Investors Still Aren't Entirely Convinced By HBM Holdings Limited's (HKG:2142) Revenues Despite 30% Price Jump

Not Many Are Piling Into HBM Holdings Limited (HKG:2142) Just Yet

Jul 18
Not Many Are Piling Into HBM Holdings Limited (HKG:2142) Just Yet

HBM Holdings (HKG:2142) Seems To Use Debt Quite Sensibly

May 23
HBM Holdings (HKG:2142) Seems To Use Debt Quite Sensibly

Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

Apr 12
Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Jan 01
HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

Feb 08
We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

May 30
HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Apr 07
Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

Mar 31
Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

Mar 10
What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

CEO Compensation Analysis

How has Jingsong Wang's remuneration changed compared to HBM Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

US$21m

Mar 31 2024n/an/a

US$22m

Dec 31 2023US$2mUS$885k

US$23m

Sep 30 2023n/an/a

-US$19m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022US$2mUS$781k

-US$137m

Sep 30 2022n/an/a

-US$143m

Jun 30 2022n/an/a

-US$149m

Mar 31 2022n/an/a

-US$144m

Dec 31 2021US$13mUS$13m

-US$138m

Sep 30 2021n/an/a

-US$224m

Jun 30 2021n/an/a

-US$310m

Mar 31 2021n/an/a

-US$303m

Dec 31 2020US$21mUS$654k

-US$296m

Compensation vs Market: Jingsong's total compensation ($USD1.59M) is above average for companies of similar size in the Hong Kong market ($USD233.11K).

Compensation vs Earnings: Jingsong's compensation has been consistent with company performance over the past year.

CEO

Jingsong Wang (59 yo)

8.3yrs

Tenure

US$1,585,000

Compensation

Dr. Jingsong Wang M.D., Ph D., serves as Chairman of Board of Directors of HBM Alpha Therapeutics, Inc. He has been Chief Executive Officer of HBM Holdings Limited and Harbour BioMed Shanghai Co., Ltd. sin...

Leadership Team

NamePositionTenureCompensationOwnership
Jingsong Wang
Founderno dataUS$1.59m8.42%
HK$ 74.1m
Yiping Rong
Chief Scientific Officer & Executive Director1.9yrsUS$547.00k0.028%
HK$ 244.7k
Youchen Chen
VP and Head of Investor Relations & Corporate Developmentless than a yearno datano data
Bruce Zhang
VP & Head of Legal Affairsno datano datano data
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Xiaolu Tao
Chief Development Officerno datano datano data
Steve Arkinstall
Chief Scientific Advisor1.4yrsno datano data
Ben Chih
Chief Scientific Officer of Neurosciences - Harbour BioMed USless than a yearno datano data
Michael Lee
Senior VP & Head of Biometricsless than a yearno datano data
Amy Jiang
VP, Chief of Staff & Head of Quality Departmentless than a yearno datano data
Yuanqing Wei
VP & Head of Translational Developmentless than a yearno datano data
Raymond Zheng
Chief Business Officerno datano datano data

0.3yrs

Average Tenure

50yo

Average Age

Experienced Management: 2142's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jingsong Wang
Founder8.3yrsUS$1.59m8.42%
HK$ 74.1m
Yiping Rong
Chief Scientific Officer & Executive Director2.5yrsUS$547.00k0.028%
HK$ 244.7k
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Robert Kamen
Independent Non-Executive Director & Member of Scientific Advisory Board7.9yrsUS$50.00k0.36%
HK$ 3.2m
Albert R. Collinson
Independent Non-Executive Director1.3yrsUS$21.00kno data
Alexander A. Zukiwski
Member of Scientific Advisory Board2.5yrsno datano data
Xiaoping Ye
Independent Non-Executive Director4yrsUS$50.00kno data
Jon Marc Wigginton
Member of Scientific Advisory Board4.4yrsno datano data
Robert Kramer
Member of Scientific Advisory Board7.9yrsno datano data
Frank Grosveld
Member of Scientific Advisory Board7.9yrsno datano data
Weiwei Chen
Senior Business Adviser & Non-Executive Director4yrsUS$50.00kno data
Zhigang Tian
Member of Scientific Advisory Board4.3yrsno datano data

4.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 2142's board of directors are considered experienced (4.3 years average tenure).